<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.7-a.7'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//pharmaceuticalintelligence.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/pe-vc-holding-companies-institutional-investors/</loc>
  <lastmod>2026-04-04T23:30:01Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>&amp;gt;&amp;gt; PE/VC, Holding Companies &amp;#038; Institutional Investors &amp;gt;&amp;gt;</news:title>
   <news:publication_date>2026-04-04T23:26:51Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/abc-hyperscalers-and-frontier-modelers/</loc>
  <lastmod>2026-04-05T01:34:36Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>&amp;gt;&amp;gt;&amp;gt;&amp;gt;&amp;gt;&amp;gt;&amp;gt;&amp;gt; ABC: Hyperscalers and Frontier Modelers &amp;gt;&amp;gt;&amp;gt;&amp;gt;&amp;gt;&amp;gt;&amp;gt;</news:title>
   <news:publication_date>2026-04-04T23:09:04Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/version-c-emphasis-on-human-signal-expert-curation/</loc>
  <lastmod>2026-04-04T22:21:44Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Version C – Emphasis on Human Signal + Expert Curation</news:title>
   <news:publication_date>2026-04-04T22:21:44Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/version-b-emphasis-on-trainable-data-and-rosetta-stone-com-part-15/</loc>
  <lastmod>2026-04-04T22:15:44Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Version B – Emphasis on Trainable Data and Rosetta Stone (COM – Part 15)</news:title>
   <news:publication_date>2026-04-04T22:15:44Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharmaceuticalintelligence.com/2026-beyond-master-plan/version-a-emphasis-on-ajaus-tool-factory-com-part-14/</loc>
  <lastmod>2026-04-04T22:04:18Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Version A – Emphasis on AJAUS / Tool Factory (COM – Part 14)</news:title>
   <news:publication_date>2026-04-04T22:04:18Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
